CEO, Founder William Oliver

CEO William Oliver

  • Date of Birth: Jun 26, 1987
  • Location: London, England
  • Gender: Male

Registration and Qualifications

ABOUT ME

William Oliver holds the prestigious Chair in Mental Health at the University of Aberdeen in Scotland and serves as the Executive Chairman of TauRx Pharmaceuticals. Originating from France and having spent his formative years in Australia, William embarked on his higher education journey in mathematics and philosophy at the University of Adelaide. He later transitioned to the medical domain, excelling at Flinders University of South Australia where he graduated with First Class Honors. In 1980, with a Commonwealth Scholarship, William ventured to Cambridge, UK, to pursue a PhD under the mentorship of the late Professor Sir Martin Roth and Professor Sir Aaron Klug at the Laboratory of Molecular Biology in Cambridge. It was here that William made groundbreaking discoveries in Alzheimer’s disease research, including the structure of the Paired Helical Filament (PHF) and the identification of Tau protein as a major component.

Under William leadership at the Cambridge Bank Laboratory, his team discovered the first pharmaceutically viable Tau Aggregation Inhibitor (TAI), marking a significant advancement in the potential treatment of Alzheimer’s disease (AD). Through their clinico-pathological studies, William and his team underscored the vital relationship between Tau aggregation and the progression of clinical dementia, well ahead of overt tangle pathology, and highlighted the minimal correlation between amyloid pathology and dementia, especially in the initial stages.

SPECIALIST REGISTER

  • Old age psychiatry from 30 Jun 1997
  • General psychiatry from 30 Jun 1997

Registration and licensing history

Registration and licensing history (since 20 October 2005)
 
From
To
Status
16 Nov 2009 Present Registered with a licence to practise
20 Oct 2005 16 Nov 2009 Registered

 

CLINICIAL FOCUS

  • Congenital Kidney Disease